RO-5006036
- Product NameRO-5006036
- CAS939375-07-2
- CBNumberCB32666919
- MFC20H19F3N4O3
- MW420.39
- MOL File939375-07-2.mol
- MSDS FileSDS
Chemical Properties
| form | Solid |
| color | Light yellow to yellow |
RO-5006036 Chemical Properties,Usage,Production
Description
RO-5006036, also known as DGAT1-IN-3, is a potent, selective and orally bioavailable inhibitor of DGAT-1Uses
DGAT1-IN-3 is a potent, selective and orally bioavailable inhibitor of DGAT-1, with IC50s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1. DGAT1-IN-3 could be used to research of obesity, dyslipidemia, and metabolic syndrome[1][2].in vivo
DGAT1-IN-3 (5-50 mg/kg; p.o once daily for three weeks) reduces weight gain and plasma triglycerides, and improves lipid profile[2].
DGAT1-IN-3 (50 mg/kg; p.o) exhibits good oral bioavailability (77%) and the maximum exposure level in plasma (Cmax) is 24 μM[2].
DGAT1-IN-3 (5 mg/kg; i.v) exhibits terminal elimination half-lives (1.95 h) and low clearance (13.5 mL/min/kg)[2].
| Animal Model: | Three-month-old male Sprague Dawley DIO rats (fed with a high-fat diet)[2] |
| Dosage: | 0, 5, 25, 50 mg/kg; once daily for three weeks |
| Administration: | P.o. administration |
| Result: | Reduced cumulative body weight gain in a dose-dependent manner and was well tolerated in rats. |
| Animal Model: | Male Wistar rats[2] |
| Dosage: | 50 mg/kg for p.o. and 5 mg/kg for i.v. (Pharmacokinetic Analysis) |
| Administration: | P.o. and i.v. administration |
| Result: | Cmax (24 μM); T1/2 (1.95 h). |
References
[1] Gómez-Outes A, et al. New parenteral anticoagulants in development. Ther Adv Cardiovasc Dis. 2011 Feb;5(1):33-59. DOI:10.1177/1753944710387808[2] Yimin Q, et, al. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes. J Med Chem. 2011 Apr 14; 54(7): 2433-46. DOI:10.1021/jm101580m
[3] Weiya Y, et, al. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors. Bioorg Med Chem Lett. 2011 Dec 1; 21(23): 7205-9.
Preparation Products And Raw materials
RO-5006036 Suppliers
Global(15)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| eric_feng1954@126.com | China | 9238 | 55 | ||
| 18916372613 | yanzihan@shyuanye.com | China | 87240 | 60 | |
| 18696571988 | amy.lei@chemieliva.com | China | 1350 | 60 | |
| 400-9205774 400-920-5774 |
sales@glpbio.cn | China | 6705 | 58 | |
| +1-708-310-1919 +1-13798911105 |
sales@invivochem.cn | United States | 6377 | 58 | |
| 18818260767 | sales@chemegen.com | China | 11123 | 58 | |
| 020-82000279 18988941452 |
YN_research@163.com | China | 2882 | 58 | |
| 13549236410 | sales@invivochem.cn | China | 6744 | 58 | |
| 4008200310 15002144251 |
marketing@tsbiochem.com | China | 24951 | 58 | |
| 021-65675885 18964387627 |
customer_service@efebio.com | China | 11963 | 58 |
939375-07-2, RO-5006036Related Search
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine